ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.
Canadian National Railway Co

Canadian National Railway Co (CNIC34R)

26.20
0.00
(0.00%)
Cerrado 05 Enero 2:55PM

Mejore su cartera: debates en tiempo real e ideas comerciales prácticas.

Estadísticas y detalles clave

Último Precio
26.20
Postura de Compra
0.00
Postura de Venta
0.00
Volume Operado de la Acción
432
0.00 Rango del Día 0.00
0.00 Rango de 52 semanas 0.00
Precio Anterior
26.20
Precio de Apertura
-
Hora
216
Última hora de negociación
Volumen promedio (3 m)
-
Volumen financiero
-
Precio Promedio Ponderado
-

CNIC34R Últimas noticias

No news to show yet.
Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
10000000DR
40000000DR
120000000DR
260000000DR
520000000DR
1560000000DR
2600000000DR

CNIC34R - Preguntas Frecuentes

¿Cuál es el precio actual de las acciones de Canadian National Railway?
El precio actual de las acciones de Canadian National Railway es R$ 26.20
¿Cuál es el rango de negociación de 1 año para el precio de las acciones de Canadian National Railway?
Canadian National Railway ha negociado en un rango de R$ 0.00 a R$ 0.00 durante el último año

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
AZEV11Azevedo Travassos Sa
R$ 0.28
(47.37%)
42.2k
JFEN3Joao Fortes Engenharia Sa
R$ 2.71
(18.34%)
239.56k
VLID3Valid Solucoes E SV De SEG EM Meios
R$ 25.00
(16.28%)
749.17k
AERI3Aeris Industria E ComerciodeEquipamentos paraGeracaodeEnergiaS.A
R$ 7.94
(13.43%)
935.03k
PINE3Banco Pine SA
R$ 4.94
(12.02%)
13.1k
COCE11Cia Energetica Ceara Coelce
R$ 0.62
(-35.42%)
10.7k
RADL3QRaia Drogasil SA
R$ 21.46
(-11.07%)
138k
AALR3Allianca Saude e Participacoes S.A.
R$ 7.27
(-9.13%)
67.2k
OFSA3Ourofino S.A
R$ 16.01
(-8.83%)
6.9k
FICT3Fictor Alimentos S.A.
R$ 3.03
(-8.18%)
39.3k
POMO4Marcopolo Sa
R$ 7.35
(-4.05%)
24.33M
CMIN3CSN Mineracao S.A
R$ 4.88
(-3.17%)
19.02M
ITUB4Itau Unibanco Holding SA
R$ 29.82
(-2.45%)
14.89M
HAPV3Hapvida Participacoes Investimento SA
R$ 2.10
(-3.23%)
13.92M
PETR3Petroleo Brasileiro S.A. Petrobras
R$ 40.38
(-0.35%)
12.65M
Red Cloud Red Cloud 5 minutos hace
Thanks so much for your response

I'll look for the text of those Warrant Agreements
FNMA
fuagf fuagf 5 minutos hace
Flip flop artist Trump is a flip, and sadly will most likely be a flop as president again.

https://www.usnews.com/object/image/00000194-1e6c-d7ea-a1d5-5fee8e950000/20241231ednac-a.jpg?update-time=1735677640116&size=responsiveGallery
barnyarddog barnyarddog 5 minutos hace
. NRx Pharmaceuticals is led by executives who have held leadership roles at Lilly, Pfizer, and Novartis as well as major investment banking institutions.



https://www.linkedin.com/company/nrx-pharma/
NRXP
Debunkinator Debunkinator 5 minutos hace
Short sellers down $180.9B in 2024 mark-to-market losses as Wall Street soars
LMAO--$$$$ Weeeeeeeeeeeeeeeeeeeeeeeee
ASII
attilathehunt attilathehunt 5 minutos hace
Somewhere in Bethesda....


Ring-a-ding-a-ring...

LP: Hello, this is Linda.

RD: Good morning Linda. This is Rob( Rob Davis, CEO of Merck)...

LP: Oh, hi Rob! I was expecting your call as soon as we received approval from the MHRA.
DJT NWBO
JR30 JR30 5 minutos hace
Shorty still crying when the SP is doing well.
VERB
dstock07734 dstock07734 6 minutos hace
I thought about the same thing. The only difference is that in my version Merck is the one who does the BLA submission to FDA. Just like what happened to the Daiichi's ADC. Here is the trial with Merck as collaborator. In October 2023, Merck and Daiichi struck the deal on three ADCs including the pl
NWBO
GetSeriousOK GetSeriousOK 6 minutos hace
OTC is entering a golden age in 2024 - Chartmaster.
OTC is entering a golden age in 2023 - Chartmaster.
OTC is entering a golden age in 2022 - Chartmaster.
I'm a genius and a millionaire - Chartmaster.

You know what they call that guy on every other board, don't y
BIEL
Monksdream Monksdream 6 minutos hace
HUH! Who wants to bet AAPL doesn’t make another new high in 2025
https://investorshub.advfn.com/uimage/uploads/2025/1/5/fngepIMG_4473.gif
AAPL
Involuntary-Recluse Involuntary-Recluse 7 minutos hace
Lmao, if only it worked that way T 😂
zab zab 7 minutos hace
I remember the real estate deferral tax deduction. I know I did not say it correctly,  but there is nothing better than claiming tax deduction on losses or gains in the future,  and using it to shield income. 
Hopeforthefuture3 Hopeforthefuture3 9 minutos hace
Eagle, imo good comparison in your post. One other item is that Kazia with paxalisib is part of the gbm AGILE program. As part of this they do have a patient level data control group. The program has 5 companies testing 5 different treatments and 1 soc control group to use as comparison with patient
NWBO
Zorax Zorax 10 minutos hace
Stupid Gets what Stupid Dose

Kind of ironic isn't it, using the wrong word about stupidity? lmao.

But then again, this just shows the tower of stupidity of trolls. I'd say the first 78 floors are empty of intelligence and the final 22 floors are just pure evil.
TURCH TURCH 12 minutos hace
Im ready for your long term play find it 😁


Regards 
marcis marcis 13 minutos hace
Ok Orlando Taddeo and his management is lying

Got it

Next
RDAR
skitahoe skitahoe 13 minutos hace
Market Beats article on AVXL

https://www.marketbeat.com/originals/short-squeeze-target-anavex-life-sciences-gains-traction/

I don't think anyone here posted this, it's complementary, but they're also pushing other stocks if you follow their link, which I didn't. I beli
AVXL JPM
JamesF1 JamesF1 14 minutos hace
Nasrat said on the last conference call that Elite sold their entire quota of Adderall. We don’t know if/when they obtained more quota. If they lost some market share on Adderall that is why. Vyvanse sales will almost all be in the current quarter, so February’s numbers MIGHT not be as impressiv
ELTP
jcromeenes jcromeenes 14 minutos hace
Yet January 16 looks to the the "exciting" day 😀
FNMA
John Doe 2024 John Doe 2024 14 minutos hace
It's none of their business what you funded or not. We can agree or disagree and argue on here but that's nobody's business but yours what you sold or didn't sell or funded.
XERI
mineanddine mineanddine 14 minutos hace
Noting that HIRU is a confirmed scam 
HIRU
surfkast surfkast 15 minutos hace
Obviously you did not even read the website. SMH
HMBL
BDEZ BDEZ 15 minutos hace
Exactly, wonder if that can be overturned by Executive order?
Samuel J Samuel J 15 minutos hace
One more thing Mr. PROBLEM with the none stop Calandar, tell me one CEO that is in the OTC that communicates as much as Josh, with a ticket on NASDAQ and a few in the OTC? 

Name me one ☝️ 

Laughable!
AZRH
FOFreddie FOFreddie 16 minutos hace
HI Red Cloud - Take a look at the Warrant Agreement - personally I did not see an anti-dilution provision but not sure. You can access from the websites - I have previously posted them so perhaps others have access to the Agreements. It would seem that the biggest dilution risk comes with earli
DJT

Su Consulta Reciente

Delayed Upgrade Clock